Moberg Pharmas shares have been quoted on the Nasdaq OMX Stock Exchange (Small Cap segment) since May 26, 2011.

CEO Peter Wolpert will present the interim report in a teleconference at 10:00 a.m. (CET) May 21, 2013. Telephone: +46 (0)8-506 26 900, and enter the code 409017 (download presentation)

Financial calendar
Interim Report January-March 2013	May 21st 2013
Interim Report January-June 2013	August 6th 2013
Interim Report January-September 2013	November 5th 2013

 

Contact Investor relations:
Magnus Persson, IR
Phone: +46 733 552 601 
Email: magnus.persson@mobergpharma.se  

 

Peter Wolpert, CEO

Phone: +46 8 522 307 08
Email: peter.wolpert@mobergpharma.se

Recent press releases

Latest financial report

 site policy

© Moberg Pharma AB 2013